These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17293493)

  • 21. Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats.
    Indolfi C; Torella D; Coppola C; Curcio A; Rodriguez F; Bilancio A; Leccia A; Arcucci O; Falco M; Leosco D; Chiariello M
    Circ Res; 2002 Dec; 91(12):1190-7. PubMed ID: 12480821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery.
    Schwarzmaier-D'Assie A; Nyolczas N; Hemetsberger R; Strehblow C; Matiasek J; Farhan S; Petrasi Z; Huber K; Wojta J; Glogar D; Plass C; Gyöngyösi M; Karnik R
    J Endovasc Ther; 2011 Aug; 18(4):547-58. PubMed ID: 21861747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10.
    Tsihlis ND; Oustwani CS; Vavra AK; Jiang Q; Keefer LK; Kibbe MR
    Cell Biochem Biophys; 2011 Jun; 60(1-2):89-97. PubMed ID: 21448667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model.
    Hou D; Narciso H; Kamdar K; Zhang P; Barclay B; March KL
    Cardiovasc Intervent Radiol; 2005; 28(1):60-5. PubMed ID: 15719180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia.
    Kapadia MR; Chow LW; Tsihlis ND; Ahanchi SS; Eng JW; Murar J; Martinez J; Popowich DA; Jiang Q; Hrabie JA; Saavedra JE; Keefer LK; Hulvat JF; Stupp SI; Kibbe MR
    J Vasc Surg; 2008 Jan; 47(1):173-82. PubMed ID: 18178471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
    J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation.
    Grassia G; Maddaluno M; Musilli C; De Stefano D; Carnuccio R; Di Lauro MV; Parratt CA; Kennedy S; Di Meglio P; Ianaro A; Maffia P; Parenti A; Ialenti A
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2458-66. PubMed ID: 20930169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
    Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.
    Torella D; Gasparri C; Ellison GM; Curcio A; Leone A; Vicinanza C; Galuppo V; Mendicino I; Sacco W; Aquila I; Surace FC; Luposella M; Stillo G; Agosti V; Cosentino C; Avvedimento EV; Indolfi C
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2015-25. PubMed ID: 19783773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery.
    Izumi Y; Kim S; Namba M; Yasumoto H; Miyazaki H; Hoshiga M; Kaneda Y; Morishita R; Zhan Y; Iwao H
    Circ Res; 2001 Jun; 88(11):1120-6. PubMed ID: 11397777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
    Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
    Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
    Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
    Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia.
    Mnjoyan ZH; Doan D; Brandon JL; Felix K; Sitter CL; Rege AA; Brock TA; Fujise K
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2276-84. PubMed ID: 18326792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.
    Yang J; Li S; Wang Q; Yang D
    Mol Med Rep; 2019 Aug; 20(2):1436-1442. PubMed ID: 31173198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.